Multidisciplinary Bladder Cancer Symposium 2024 - Enduring Materials

Our faculty will discuss clinical and technical advances, promising clinical trials data, national guidelines and key controversies in the management of bladder cancer. Through leading-edge lectures, case discussion and interactive question and answer sessions, this program will provide participants with an enhanced ability to apply best treatment options into their individual cancer practices.

Click the Activity Instructions button for more info.

Once registration is complete please click the Begin Activity tab to launch the video.

You must complete the pre and/or post-test and evaluation to receive CME credit. 

1. Prescribe new advancements and innovations in the treatment of bladder cancer
2. Implement a multidisciplinary approach to the management of bladder cancer
3. Develop a patient-centered approach to the management of bladder cancer
4. Apply principles of bladder cancer management to complex cases

Henry Ford Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION STATEMENT:

Henry Ford Health designates this live course for a maximum of 4.50 AMA PRA Category 1 Credit(s) TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

FACULTY/PLANNING COMMITTEE DISCLOSURE STATEMENT: 

 In compliance with the ACCME standards for Commercial Support, all individuals in a position to control/influence the content of this activity are required to disclose all financial interests of their own with any ACCME defined commercial interests for the past 24 months and/or non-FDA approved use of a drug or a device that is included in the presentation. All financial relationships have been mitigated prior to the commencement of the activity.

ACCESSIBILITY STATEMENT: 

Henry Ford Health provides qualified interpreters and other aids for Deaf, DeafBlind, and Hard-of-Hearing persons at no cost. To request assistance, contact the event coordinator: (CME Specialist email here). Please allow a minimum of 3 days to process this request.

Cancellation Policy

Please send cancellation requests to [email protected].

Henry Ford Health Office of Continuing Medical Education reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

The Henry Ford Health Office of Continuing Medical Education adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Henry Ford Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Clara Hwang, MD
Henry Ford Medical Group

Activity Coordinator, Course Director, Faculty

Grant or research support-Seagen|Grant or research support-Bayer|Grant or research support-AstraZeneca|Grant or research support-Genentech|Grant or research support-Merck

Crystal M Gyiraszin, MS
HFHS

CME Reviewer

Nothing to disclose

Michelle Clayton, BA
Henry Ford Health

CME Specialist

Nothing to disclose

Johar Raza, MD
Henry Ford Hospital

Course Director, Faculty

Piyush Agarwal, MD
University of Chicago

Faculty

Advisor-Janssen (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Astrazeneca (Relationship has ended)|Advisor-Verity (Relationship has ended)|Advisor-Urogen (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Nonagen|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Aura (Relationship has ended)

David Bergman, MD
Henry Ford Health

Faculty

Melissa Huynh, MD, MPH
Western University
Canada

Faculty

Honoraria-Knight Therapeutics and Astellas

Roger Li, MD
Moffitt Cancer Center

Faculty

Consulting Fee-BMS (Relationship has ended)|Consulting Fee-Merck (Relationship has ended)|Grant or research support-Merck|Consulting Fee-CG Oncology (Relationship has ended)|Grant or research support-Predicine|Grant or research support-Veractye|Grant or research support-Valar labs

Jeffrey Montgomery, MD
University of Michigan

Faculty

Nothing to disclose

James Peabody, MD
Vattikuti Urology Institute, Henry Ford Hospital

Faculty

Nothing to disclose

Craig Rogers, MD
Vattikuti Urology Institute, Henry Ford Hospital

Faculty

Nothing to disclose

Michael Ryan, PsyD
Henry Ford Health System

Faculty

Nothing to disclose

Ulka Vaishampayan, MD
University of Michigan

Faculty

Grant or research support-Merck, BMS|Consulting Fee- Astellas, Mural, Merck, Exelixis, Gilead, Novartis, BMS, Pfizer, Bayer|Honoraria-Exelixis, Sanofi, Bayer, Pfizer